Investigation of antibody titers is essential for patients who have neuropathy with cerebellar ataxia and do not respond to IVIG treatment.
Braingate technology allows patients with tetrapalegia to move a computer cursor by thinking about it.
Lauren Elman, MD
Treating adult patients with antisense oligonucleotide therapy proven effective in children presents unique challenges.
Asseel Albayati, MD; Safa AlJammali, MD; Mohammed AlKhero, MD; and Aziz Shaibani, MD
Investigation of antibody titers is essential for patients who have neuropathy with cerebellar ataxia and do not respond to IVIG treatment.
Arash Salardini, MD
The second most prevalent form of dementia has effective symptomatic treatments available.
Daniel Kantor, MD, FAAN, FANA
A potential new first-in-class treatment affects Bruton’s tyrosine kinase.
Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.
